Amedisys (NASDAQ:AMED) Downgraded by William Blair to “Market Perform”

William Blair lowered shares of Amedisys (NASDAQ:AMED) from an outperform rating to a market perform rating in a research note issued to investors on Monday morning, Marketbeat reports.

A number of other analysts also recently commented on AMED. Cantor Fitzgerald reaffirmed a neutral rating and set a $101.00 price target on shares of Amedisys in a research report on Thursday, April 25th. Raymond James reaffirmed a market perform rating on shares of Amedisys in a research report on Tuesday, March 26th. StockNews.com raised Amedisys from a hold rating to a buy rating in a research report on Saturday, May 4th. Finally, Royal Bank of Canada raised their target price on Amedisys from $97.00 to $100.00 and gave the stock an outperform rating in a research report on Monday, March 25th. Five equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of Hold and an average target price of $100.67.

Amedisys Stock Up 5.3 %

AMED stock opened at $96.68 on Monday. Amedisys has a twelve month low of $89.55 and a twelve month high of $97.36. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.31. The stock’s 50 day moving average is $93.20 and its 200-day moving average is $93.44. The firm has a market capitalization of $3.16 billion, a PE ratio of -151.06, a P/E/G ratio of 2.25 and a beta of 0.79.

Amedisys (NASDAQ:AMED) last posted its earnings results on Wednesday, April 24th. The health services provider reported $1.03 earnings per share for the quarter, beating analysts’ consensus estimates of $1.02 by $0.01. The company had revenue of $571.41 million for the quarter, compared to analyst estimates of $565.38 million. Amedisys had a positive return on equity of 12.85% and a negative net margin of 0.91%. The company’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same quarter last year, the company earned $1.00 earnings per share. Sell-side analysts expect that Amedisys will post 4.57 EPS for the current fiscal year.

Institutional Investors Weigh In On Amedisys

Several hedge funds have recently added to or reduced their stakes in AMED. Vanguard Group Inc. lifted its stake in Amedisys by 0.4% in the third quarter. Vanguard Group Inc. now owns 3,241,160 shares of the health services provider’s stock worth $302,724,000 after purchasing an additional 12,137 shares during the last quarter. Alpine Associates Management Inc. lifted its stake in Amedisys by 23.0% in the fourth quarter. Alpine Associates Management Inc. now owns 1,271,097 shares of the health services provider’s stock worth $120,830,000 after purchasing an additional 237,600 shares during the last quarter. Westchester Capital Management LLC increased its position in shares of Amedisys by 3.4% during the fourth quarter. Westchester Capital Management LLC now owns 879,402 shares of the health services provider’s stock worth $83,596,000 after acquiring an additional 29,016 shares during the period. Park West Asset Management LLC increased its position in shares of Amedisys by 8.0% during the fourth quarter. Park West Asset Management LLC now owns 812,069 shares of the health services provider’s stock worth $77,195,000 after acquiring an additional 60,350 shares during the period. Finally, Water Island Capital LLC increased its position in shares of Amedisys by 185.0% during the fourth quarter. Water Island Capital LLC now owns 710,697 shares of the health services provider’s stock worth $67,559,000 after acquiring an additional 461,368 shares during the period. Institutional investors own 94.36% of the company’s stock.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.